Skip to content

Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis

Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04744220
Enrollment
60
Registered
2021-02-08
Start date
2020-11-25
Completion date
2022-12-30
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis Adult

Keywords

Yoga Training, Quality of Life, Functional Capacity, Bronchiectasis

Brief summary

Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients with Bronchiectasis between the ages of 30-55

Detailed description

Investigating the effect of yoga training on functional capacity and quality of life and comparing with previous studies

Interventions

OTHERYoga Training Program (exercises)

Training: Before the yoga program, the patients will be informed about the bronchiectasis disease and its symptoms, as well as all the parameters used in the evaluation, tests and the content of the yoga session. The patients will start with breathing exercises, then relaxation exercises, warm-up exercises, asanas (posture exercises) and finally the yoga training program will be completed with deep relaxation technique.

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The cases will be randomly divided into two groups as 24 control groups and 24 yoga training groups

Eligibility

Sex/Gender
ALL
Age
30 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with bronchiectasis * Age 30-55 * Not having a known systemic, orthopedic or neurological disease

Exclusion criteria

* Severe heart failure * People who had an acute exacerbation up to three weeks ago will not be included in the study

Design outcomes

Primary

MeasureTime frameDescription
Patient Follow-up FormBaselineThe demographic characteristics, physical characteristics such as age, height and body weight of the individuals included in the study and their education status will be recorded.

Secondary

MeasureTime frameDescription
Dyspnea AssessmentBefore and after treatment (8 week)Dyspnea will be assessed by the modified Medical Research Council (MMRC) dyspnea scale. Individuals will be asked to choose the statement that best describes their dyspnea level. Scoring in MMRC varies between 0-4 points. 0 points means that there is no dyspnea; 4 points indicates a perception of dyspnea during basic daily life activities such as dressing.

Other

MeasureTime frameDescription
Respiratory Function TestBefore and after treatment( 8 week )A spirometer will be used to evaluate the lung function of individuals. It will be expressed as a percentage of the expected values by age, height, body weight and gender.
Quality of Life AssessmentBefore and after treatment (8 week)Quality of life, St. George's Respiratory Questionnaire (SGRQ). SGRQ is a health-related quality of life questionnaire that questions a total of 50 items under 3 main components: symptoms (8 items), activity (16 items) and effects of disease (26 items). The symptoms component includes the frequency and duration of symptoms such as cough, sputum, shortness of breath, wheezing. The activity component relates to physical activities that are restricted due to shortness of breath. It includes factors such as the effects component of the disease, the drugs used and its side effects, the individual's expectations for health and the discomfort they face in daily life. The total score is between 0-100. The higher the score, the lower the quality of life
Evaluation of Functional CapacityBefore and after treatment (8 week)Individuals' functional capacity will be evaluated with the six-minute walking test (6MWT). During the 6MWT, individuals are asked to walk in a straight corridor of 30 meters as fast as possible, at their own walking pace in standard directions. At the end of the test, the walking distance is recorded in meters.
Assessment of Sleep QualityBefore and after treatment (8 week)Pittsburgh Sleep Quality Index (PSQI) will be used to evaluate the sleep quality of the individuals participating in our study before and after the 8-week study period. PSQI is a test that plays a role in determining sleep quality and sleep-related disorders in the last month. It is a scale consisting of 19 self-report items, a total of 24 questions with a score range of 0-21, and the remaining five questions must be answered by a roommate or a spouse. It is a test that evaluates a wide variety of areas related to sleep quality, including components, sleep time, delays in falling asleep, the frequency and severity of sleep-related problems, and the impact of poor sleep on an individual's work.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026